Vanguard Group Inc Sutro Biopharma, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,555,340 shares of STRO stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,555,340
Previous 3,022,790
17.62%
Holding current value
$12.6 Million
Previous $17.1 Million
39.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STRO
# of Institutions
128Shares Held
63MCall Options Held
200Put Options Held
27.6K-
Suvretta Capital Management, LLC New York, NY7.71MShares$27.4 Million0.94% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$24.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.45MShares$15.8 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.36MShares$15.5 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.04MShares$10.8 Million1.43% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $185M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...